Literature DB >> 27640196

Patterns of multidisciplinary care in the management of non-metastatic invasive breast cancer in the United States Medicare patient.

Thomas M Churilla1, Brian L Egleston2, Colin T Murphy1, Elin R Sigurdson3, Shelly B Hayes1, Lori J Goldstein4, Richard J Bleicher5.   

Abstract

PURPOSE: Multidisciplinary care (MDC) in managing breast cancer is resource-intensive and growing in prevalence anecdotally, although care patterns are poorly characterized. We sought to determine MDC patterns and effects on care in the United States Medicare patient.
METHODS: Patients diagnosed with non-metastatic invasive breast cancer from 1992-2009 were reviewed using the Survival, Epidemiology, and End Results (SEER)-Medicare linked dataset. MDC was defined as a post-diagnosis, preoperative visit with a surgical, medical, and radiation oncologist. Same-day MDC (MDCSD) was the MDC subset having all three visits on one date.
RESULTS: Among 88,865 patients, MDC was utilized in 2.9 %, with 14.1 % of these having MDCSD. MDC use did not vary by stage, but MDC patients were more likely to be younger, black, receive lumpectomy, have fewer nodes examined, and receive radiotherapy. MDCSD patients were more likely than non-MDC patients to be black, receive mastectomy, and receive radiotherapy. MDC and MDCSD use increased over time and varied by geographic region, with rural patients less likely to receive MDC (OR 0.54 [95 % CI 0.45-0.65]) and MDCSD (OR 0.32 [95 % CI 0.19-0.54]). Radiotherapy after breast conserving surgery, used in 86.2 % of non-MDC patients, was administered to 90.2 % of MDC (p < 0.001) and 92.6 % of MDC(SD) (p = 0.096) patients. Post-mastectomy radiotherapy was administered in 52.0 % of non-MDC patients, 63.8 % of MDC (p = 0.050), and 89.1 % of MDC(SD) (p = 0.011) patients after propensity score adjustment.
CONCLUSION: While increasing, few Medicare patients undergo MDC and MDCSD is rare. MDC may improve quality and MDCSD should be considered for patient convenience. While not yet widespread, efforts should integrate MDC and MDCSD across the U.S.

Entities:  

Keywords:  Breast cancer; Medical oncology; Multidisciplinary care; Radiation oncology; Surgical oncology

Mesh:

Year:  2016        PMID: 27640196      PMCID: PMC5064835          DOI: 10.1007/s10549-016-3982-x

Source DB:  PubMed          Journal:  Breast Cancer Res Treat        ISSN: 0167-6806            Impact factor:   4.872


  22 in total

1.  Stratification and weighting via the propensity score in estimation of causal treatment effects: a comparative study.

Authors:  Jared K Lunceford; Marie Davidian
Journal:  Stat Med       Date:  2004-10-15       Impact factor: 2.373

2.  Impact of a prostate multidisciplinary clinic program on patient treatment decisions and on adherence to NCCN guidelines: the William Beaumont Hospital experience.

Authors:  Howard Korman; Thomas Lanni; Chirag Shah; Jan Parslow; Joyce Tull; Mihai Ghilezan; Daniel Krauss; Savitha Balaraman; Kenneth Kernen; Matthew Cotant; Jeffrey Margolis; Frank A Vicini
Journal:  Am J Clin Oncol       Date:  2013-04       Impact factor: 2.339

Review 3.  Quality of care management decisions by multidisciplinary cancer teams: a systematic review.

Authors:  Benjamin W Lamb; Katrina F Brown; Kamal Nagpal; Charles Vincent; James S A Green; Nick Sevdalis
Journal:  Ann Surg Oncol       Date:  2011-03-26       Impact factor: 5.344

4.  A new method of classifying prognostic comorbidity in longitudinal studies: development and validation.

Authors:  M E Charlson; P Pompei; K L Ales; C R MacKenzie
Journal:  J Chronic Dis       Date:  1987

5.  Preoperative delays in the US Medicare population with breast cancer.

Authors:  Richard J Bleicher; Karen Ruth; Elin R Sigurdson; Eric Ross; Yu-Ning Wong; Sameer A Patel; Marcia Boraas; Neal S Topham; Brian L Egleston
Journal:  J Clin Oncol       Date:  2012-11-19       Impact factor: 44.544

6.  Enhancing prostate cancer care through the multidisciplinary clinic approach: a 15-year experience.

Authors:  Leonard G Gomella; Jianqing Lin; Jean Hoffman-Censits; Patricia Dugan; Fran Guiles; Costas D Lallas; Jaspreet Singh; Peter McCue; Timothy Showalter; Richard K Valicenti; Adam Dicker; Edouard J Trabulsi
Journal:  J Oncol Pract       Date:  2010-11       Impact factor: 3.840

7.  Models of multidisciplinary cancer care: physician and patient perceptions in a comprehensive cancer center.

Authors:  Craig A Bunnell; Saul N Weingart; Scott Swanson; Harvey J Mamon; Lawrence N Shulman
Journal:  J Oncol Pract       Date:  2010-11       Impact factor: 3.840

8.  Team dynamics, decision making, and attitudes toward multidisciplinary cancer meetings: health professionals' perspectives.

Authors:  Bianca Devitt; Jennifer Philip; Sue-Anne McLachlan
Journal:  J Oncol Pract       Date:  2010-11       Impact factor: 3.840

Review 9.  Surgical leadership and standardization of multidisciplinary breast cancer care: the evolution of the National Accreditation Program for Breast Centers.

Authors:  Jessica Bensenhaver; David P Winchester
Journal:  Surg Oncol Clin N Am       Date:  2014-07       Impact factor: 3.495

10.  Comparisons between different polychemotherapy regimens for early breast cancer: meta-analyses of long-term outcome among 100,000 women in 123 randomised trials.

Authors:  R Peto; C Davies; J Godwin; R Gray; H C Pan; M Clarke; D Cutter; S Darby; P McGale; C Taylor; Y C Wang; J Bergh; A Di Leo; K Albain; S Swain; M Piccart; K Pritchard
Journal:  Lancet       Date:  2011-12-05       Impact factor: 79.321

View more
  9 in total

Review 1.  Update of the American Society of Breast Surgeons Toolbox to address the lumpectomy reoperation epidemic.

Authors:  Maureen P McEvoy; Jeffrey Landercasper; Himani R Naik; Sheldon Feldman
Journal:  Gland Surg       Date:  2018-12

Review 2.  Multidisciplinary care of breast cancer patients: a scoping review of multidisciplinary styles, processes, and outcomes.

Authors:  J Shao; M Rodrigues; A L Corter; N N Baxter
Journal:  Curr Oncol       Date:  2019-06-01       Impact factor: 3.677

3.  Time to Surgery and the Impact of Delay in the Non-Neoadjuvant Setting on Triple-Negative Breast Cancers and Other Phenotypes.

Authors:  Alina M Mateo; Anna M Mazor; Elias Obeid; John M Daly; Elin R Sigurdson; Elizabeth A Handorf; Lyudmila DeMora; Allison A Aggon; Richard J Bleicher
Journal:  Ann Surg Oncol       Date:  2019-11-11       Impact factor: 5.344

Review 4.  Timing and Delays in Breast Cancer Evaluation and Treatment.

Authors:  Richard J Bleicher
Journal:  Ann Surg Oncol       Date:  2018-07-02       Impact factor: 5.344

5.  Cancer prevention, risk reduction, and control: opportunities for the next decade of health care delivery research.

Authors:  Denalee M O'Malley; Catherine M Alfano; Michelle Doose; Anita Y Kinney; Simon J Craddock Lee; Larissa Nekhlyudov; Paul Duberstein; Shawna V Hudson
Journal:  Transl Behav Med       Date:  2021-11-30       Impact factor: 3.046

Review 6.  The Relationship between Time to Surgery (TTS) and Survival in Breast Cancer: A Systematic Review and Meta-Analysis.

Authors:  Yongcheng Su; Xiaogang Zheng; Zhong Ouyang
Journal:  Iran J Public Health       Date:  2021-09       Impact factor: 1.429

7.  Comorbidity Management in Black Women Diagnosed with Breast Cancer: the Role of Primary Care in Shared Care.

Authors:  Michelle Doose; Michael B Steinberg; Cathleen Y Xing; Yong Lin; Joel C Cantor; Chi-Chen Hong; Kitaw Demissie; Elisa V Bandera; Jennifer Tsui
Journal:  J Gen Intern Med       Date:  2020-09-24       Impact factor: 5.128

8.  Compliance with multidisciplinary team recommendations and disease outcomes in early breast cancer patients: An analysis of 4501 consecutive patients.

Authors:  Xingxia Yang; Jiahui Huang; Xiaoping Zhu; Kunwei Shen; Juanying Zhu; Xiaosong Chen
Journal:  Breast       Date:  2020-05-28       Impact factor: 4.380

9.  Scoping clinicians' perspectives on pre-treatment multidisciplinary care for young women with breast cancer.

Authors:  Arden L Corter; May Lynn Quan; Frances L Wright; Erin D Kennedy; Marko Ri Simunovic; Juliet Shao; Nancy N Baxter
Journal:  J Multidiscip Healthc       Date:  2018-10-09
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.